Imiquimod
Specifications
99011-02-6CAS Number
618-567-3EC Number
1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amineIUPAC Name
C14H16N4Chemical Formula
240.3 g/molMolecular Weight
IMIQUIMOD; 99011-02-6; Aldara; 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine; Zyclara; 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine; 4-Amino-1-isobutyl-1H-imidazo[4,5-c]quinoline; R-837; R 837; 4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline; S-26308; DTXSID7041047; TMX-101; Imiquimodum; S 26308; S26308; NSC-369100; NSC-759651; P1QW714R7M; TMX 101; 1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-; R837; 1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)-; DTXCID5021047; CHEBI:36704; 1-isobutyl-1H-imidazo(4,5-c)quinolin-4-amine; NSC369100; 1-(2-methylpropyl)-1H-imidazo(4,5-c)quinolin-4-amine; RefChem:57767; D06BB10; NSC741062; 619-387-8; Beselna; 9050-31-1; 1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine; (Hydroxypropyl)methyl cellulose phthalate; MFCD00866946; 1-(2-Methylpropyl)-1H-imidazole[4,5-c]quinoline-4-amine; 1-isobutylimidazo[4,5-c]quinolin-4-amine; CHEMBL1282; NCGC00070736-02; Zartra; Imiquimod acetate; Hpmcp; Aldara (TN); CAS-99011-02-6; SR-01000611320; UNII-P1QW714R7M; Imiqimod; Imiquimod [USAN:INN:BAN]; Vyloma; imiquimod?; MTD-39; HSDB 8129; 6T0; Zyclara (TN); Imiquimod (Standard); DZ-2636; Hydroxypropyl Methyl Cellulose Phthalate; IMIQUIMOD [INN]; IMIQUIMOD [JAN]; IMIQUIMOD [MI]; IMIQUIMOD [USAN]; IMIQUIMOD [VANDF]; Hypromellose phthalate CRS; IMIQUIMOD [MART.]; Cellulose, hydrogen 1,2-benzenedicarboxylate, 2-hydroxypropyl methyl ether; IMIQUIMOD [USP-RS]; IMIQUIMOD [WHO-DD]; Imiquimod (JAN/USP/INN); 4-amino- 1-isobutyl-1h-imidazo[4,5-c]quinoline; SCHEMBL26136; IMIQUIMOD [EMA EPAR]; MLS000083577; BIDD:GT0859; Imiquimod - Bio-X trade mark; GTPL5003; orb1223472; orb1310904; orb3025454; IMIQUIMOD [ORANGE BOOK]; SCHEMBL29357252; HY-B0180R; IMIQUIMOD [USP MONOGRAPH]; GLXC-05818; HMS2090M14; HMS2232G07; HMS3373B13; HMS3715N19; HMS3747A13; HMS5087E15; Pharmakon1600-01502351; ALBB-038634; HY-B0180; MSK10029; Tox21_110985; AC-529; BBL010772; BDBM50240849; EBC-07888; HB3109; NSC759651; NSC811538; NSC828389; s1211; STK583860; Imiquimod, >=98% (HPLC), solid; AKOS005507352; Tox21_110985_1; 1H-Imidazo[4, 1-(2-methylpropyl)-; CCG-208015; CS-2058; DB00724; FI24563; KS-5218; NSC 369100; NSC 741062; NSC 759651; NSC-811538; NSC-828389; YH44175; Imiquimod 100 microg/mL in Acetonitrile; NCGC00070736-03; NCGC00070736-04; NCGC00070736-05; NCGC00070736-07; BI164576; SMR000048307; SY017571; I0747; I5034; NS00006714; D02500; 1-isobutyl-1H-imidazo [4,5-c]quinolin-4-amine; 1-isobutyl-1H-imidazo[4,5-c]quinoline-4-amine; AB00399298-05; AB00399298-06; AB00399298-07; AB00399298_08; AB00399298_09; EN300-6477856; 1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-ylamine; F386709; Q423417; SR-01000611320-2; SR-01000611320-3; BRD-K26657438-001-01-2; BRD-K26657438-001-13-7; BRD-K26657438-001-15-2; BRD-K26657438-001-17-8; BRD-K26657438-003-01-8; 1-(2-methylpropyl)-1Himidazo[4,5-c]quinolin-4-amine; Z2588038940; 1-(2-methylpropyl)-1H-imidazo[4,5-c]-quinolin-4-amine; Imiquimod, United States Pharmacopeia (USP) Reference StandardSynonyms
No companies, products, or articles found for this substance yet.